Raytone Biotech, a biotech company that focuses on creating new treatments for eye diseases, has shared that the first patient was given the treatment RTP-008
Randomized sub-trial 1 of a global adaptive platform trial of COM701 maintenance therapy in patients with relapsed platinum sensitive ovarian cancer Compugen Ltd, a clinical-stage
Phase 3 Top Line Results Expected Q2 2026 Lipocine Inc, a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with effective oral
Bio-Thera Solutions , a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, announced that dosing has begun in a phase 3 clinical study
Fuel up with free Health Tech Insights
